Skip to content

Anecortave

SENSORY ORGANS

Also known as: anecortave acetate, retaane

YEAR INTRODUCED approvedATC S01LA02

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Anecortave is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 2006. DrugCentral lists 1 molecular target, including SERPINE1. Recorded indications include Exudative age-related macular degeneration.

  • Molecular targets: SERPINE1 (1 listed in DrugCentral).
  • Indications: Exudative age-related macular degeneration.
  • ATC code: S01LA02 (Antineovascularisation agents).
  • Molecular formula: C23H30O5; molecular weight 386.49 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Exudative age-related macular degeneration

Mechanism & targets

Molecular targets (1)

TargetGeneActionActivity
Plasminogen activator inhibitor 1SERPINE1unknown—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
2006-01-01YEAR INTRODUCED——

ATC classification

ATC codeTherapeutic hierarchy
S01LA02SENSORY ORGANS › OPHTHALMOLOGICALS › OCULAR VASCULAR DISORDER AGENTS › Antineovascularisation agents

Chemical structure

Molecular formulaC23H30O5
Molecular weight386.49 g/mol
CAS number—
InChIKeyYUWPMEXLKGOSBF-GACAOOTBSA-N
PubChem CID7074810
CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)C3=CC[C@]12C

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Anecortave used for?

DrugCentral lists the following indications for Anecortave: Exudative age-related macular degeneration.

How does Anecortave work?

Its molecular targets in DrugCentral include SERPINE1.

When was Anecortave first approved?

Anecortave was first approved by the YEAR INTRODUCED in 2006.

What is the chemical formula of Anecortave?

Anecortave has the molecular formula C23H30O5 and a molecular weight of 386.49 g/mol.

Browse: all drugs starting with A · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval2006-01-01
AgencyYEAR INTRODUCED
Targets1
Indications1
FormulaC23H30O5
DrugCentral ID217
Interactive profile